Launch Doctors

Structure. Clarity. Momentum.

We help emerging and mid-sized BioPharma companies diagnose launch risks and build integrated plans for a successful commercial launch.

Built for teams who have one or more of the following:

  • Have an asset roughly 12–36 months from launch
  • Have limited in-house launch capability
  • Are preparing for a first or second commercial launch
  • Need alignment across key functions, including medical, market access, marketing, regulatory, supply and comms
  • Want experienced support

Experience across leading biopharma companies

Galápagos
Novartis
Allergan
Sanofi
Regeneron
Janssen, Pharmaceutical Companies of Johnson & Johnson
GSK
Ipsen
Galápagos
Novartis
Allergan
Sanofi
Regeneron
Janssen, Pharmaceutical Companies of Johnson & Johnson
GSK
Ipsen
Four Focused Offers

Each one solves a specific problem on the journey to launch. Start with a Launch Health Check, or go straight to the support you need.

Led by Real Launch Experience

Client Example Request

A mid-sized biopharma company approaching its first commercial launch in years engaged Launch Doctors for a Launch Health Check roughly 24 months ahead of anticipated approval. The assessment surfaced gaps in cross-functional alignment between medical, market access and commercial teams, along with unclear ownership across key launch milestones. The resulting recommendations informed an Integrated Launch Plan, giving leadership a single, governed view of the path to launch.

Avi Leaf, Founder

Avi Leaf, Founder

25+ years of global BioPharma and consulting experience across large, medium and small BioPharma companies, with deep expertise launching, commercialising and building growth for product portfolios.

“Launch Doctors provided excellent strategic direction for the brand and leadership to the team, which has ensured an excellent foundation for the business moving forward.”

— Client testimonial
Contact Us